LINGERIE FIGHTING CHAMPIONSHIPS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LINGERIE FIGHTING CHAMPIONSHIPS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.5K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $133.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $117.7K | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $113.8K | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | $95.4K | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | $27.8K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $27.4K | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | $12.7K | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | $15.5K | Apr 16, 2019 |
| FY2011 | Feb 29, 2012 | $502.1K | Jul 10, 2012 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $15.5K | Jul 20, 2018 |
| FY2017 | Dec 31, 2016 | $72.7K | Jul 20, 2018 |
| FY2016 | Dec 31, 2015 | $6.0K | Jun 1, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($29.2K) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $48.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $48.8K | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $80.0K | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | ($809) | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | $124 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($11.4K) | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | ($11.9K) | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | ($38.3K) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($34.4K) | Jul 20, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($567.2K) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($1.87M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $308.5K | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $1.68M | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | ($3.52M) | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | ($2.41M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($2.30M) | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | $66.8K | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | ($1.56M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($1.80M) | Jul 20, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($450.0K) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($344.5K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($223.6K) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($189.2K) | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | ($412.5K) | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | ($232.9K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($221.9K) | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | ($250.5K) | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | ($323.0K) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($1.80M) | Jul 20, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.6K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $56.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $62.5K | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $71.2K | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | $124.6K | Jul 18, 2023 |
| FY2015 | Feb 28, 2015 | $136.8K | Jun 3, 2015 |
| FY2015 | Feb 28, 2014 | $260.2K | Jun 3, 2015 |
| FY2013 | Feb 28, 2013 | $350.8K | May 29, 2014 |
| FY2012 | Feb 29, 2012 | $204.8K | Jun 13, 2013 |
| FY2011 | Feb 28, 2011 | $2.81M | Jul 10, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($312.8K) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($161.5K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($150.2K) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($88.0K) | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | ($265.7K) | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | ($78.9K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($164.7K) | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | ($156.1K) | Apr 8, 2021 |
| FY2013 | Feb 28, 2014 | ($145.3K) | May 29, 2014 |
| FY2013 | Feb 28, 2013 | ($281.0K) | May 29, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $2.6K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Apr 11, 2025 |
| FY2011 | Feb 29, 2012 | $29.1K | Jul 10, 2012 |
| FY2011 | Feb 28, 2011 | $196.8K | Jul 10, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.2K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.6K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $5.3K | Apr 11, 2025 |
| FY2015 | Feb 28, 2015 | $3.6K | Jun 3, 2015 |
| FY2015 | Feb 28, 2014 | $35.6K | Jun 3, 2015 |
| FY2013 | Feb 28, 2013 | $6.0K | May 29, 2014 |
| FY2012 | Feb 29, 2012 | $471.2K | Jun 13, 2013 |
| FY2011 | Feb 28, 2011 | $1.54M | Jul 10, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.44M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $5.94M | Mar 30, 2026 |
| FY2015 | Feb 28, 2015 | $42.1K | Jun 3, 2015 |
| FY2015 | Feb 28, 2014 | $215.4K | Jun 3, 2015 |
| FY2013 | Feb 28, 2013 | $225.6K | May 29, 2014 |
| FY2012 | Feb 29, 2012 | $2.19M | Jun 13, 2013 |
| FY2011 | Feb 28, 2011 | $4.06M | Jul 10, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.33M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($5.93M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | ($4.20M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | ($4.57M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2021 | ($6.37M) | Jul 15, 2024 |
| FY2022 | Dec 31, 2020 | ($5.88M) | Jul 18, 2023 |
| FY2021 | Dec 31, 2019 | ($4.37M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($2.33M) | Jun 7, 2021 |
| FY2019 | Dec 31, 2017 | ($2.46M) | Apr 8, 2021 |
| FY2018 | Dec 31, 2016 | ($1.23M) | Apr 16, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.74M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($11.17M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($9.30M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($9.61M) | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | ($11.72M) | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | ($8.20M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($5.79M) | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | ($3.49M) | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | ($3.56M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($2.00M) | Jul 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $10.0K | Jul 18, 2023 |
| FY2022 | Dec 31, 2021 | $34.5K | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | $4.1K | Mar 31, 2022 |
| FY2021 | Dec 31, 2019 | $43.7K | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $3.4K | Jun 7, 2021 |
| FY2019 | Sep 30, 2018 | $34.5K | Apr 8, 2021 |
| FY2019 | Dec 31, 2017 | $28.4K | Apr 8, 2021 |
| FY2018 | Dec 31, 2016 | $60.1K | Apr 16, 2019 |
| FY2017 | Dec 31, 2015 | $21.7K | Jul 20, 2018 |
| FY2015 | Feb 28, 2015 | $3.6K | Jun 3, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jul 15, 2024 |
| FY2019 | Dec 31, 2019 | 0 | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 8, 2021 |
| FY2011 | Feb 29, 2012 | 0 | Jul 10, 2012 |
| FY2011 | Feb 28, 2011 | 0 | Jul 10, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jul 18, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 8, 2021 |
| FY2011 | Feb 29, 2012 | 0 | Jul 10, 2012 |
| FY2011 | Feb 28, 2011 | 0 | Jul 10, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 555,651 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 450,485 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 3.90B | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 3.71B | Jul 15, 2024 |
| FY2022 | Dec 31, 2021 | 3.54B | Jul 18, 2023 |
| FY2021 | Dec 31, 2020 | 2.34B | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 2.02B | Jun 7, 2021 |
| FY2019 | Dec 31, 2018 | 770.40M | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | 576.19M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 87.68M | Jul 20, 2018 |